Hulio Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Hulio General Information
Description
Global Rights of global rights for Hulio (biosimilar Adalimumab).
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
- Japan
Primary Industry
Buildings and Property
Acquirer
Corporate Office
- Japan
Hulio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hulio Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hulio FAQs
-
Where is Hulio headquartered?
Hulio is headquartered in Japan.
-
What industry is Hulio in?
Hulio’s primary industry is Buildings and Property.
-
Is Hulio a private or public company?
Hulio is a Private company.
-
What is Hulio’s current revenue?
The current revenue for Hulio is .
-
Who are Hulio’s investors?
Fujifilm Kyowa Kirin Biologics Company has invested in Hulio.
-
When was Hulio acquired?
Hulio was acquired on 23-Dec-2025.
-
Who acquired Hulio?
Hulio was acquired by Biocon Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process